Track topics on Twitter Track topics that are important to you
DUBLIN, Ireland, July 27, 2015 (GLOBE NEWSWIRE) -- GC Aesthetics plc ("GC Aesthetics" or the "Company"), a leading pure-play female aesthetics company, today announced that it has commenced an initial public offering of 5,350,000 of its ordinary shares. The price range for the initial public offering is currently estimated to be between $13 and $15 per share. The underwriters of the offering will have a 30-day option to purchase up to an additional 802,500 of the Company's ordinary shares. The Company has applied to list its ordinary shares on the NASDAQ Global Market under the ticker symbol "GCAA."
BofA Merrill Lynch, Deutsche Bank Securities and Cowen and Company are acting as joint book running managers for the proposed offering. William Blair is acting as co-manager for the proposed offering.
The offering will be made only by means of prospectus. A copy of the preliminary prospectus relating to the offering may be obtained from either BofA Merrill Lynch, at 222 Broadway, New York, New York 10038, Attention: Prospectus Department or by e-mail at email@example.com, or Deutsche Bank Securities, at 60 Wall Street, New York, New York 10005, Attention: Prospectus Department or by email at firstname.lastname@example.org.
A registration statement on Form F-1 relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About GC Aesthetics
GC Aesthetics is a leading pure-play female aesthetics company committed to becoming the trusted brand and partner for women seeking to look healthy, youthful, vibrant and beautiful, and to feel confident about themselves throughout their lifetime. The Company is focused on the development, manufacturing and commercialization of one of the broadest ranges of implant products, principally silicone breast implants. Its two brands, Nagôr and Eurosilicone, have a combined 60 years of market presence and its products are sold in 75 countries. The Company has manufacturing facilities in the United Kingdom and France and its implants are manufactured with medical-grade silicone supplied from ISO 9001-certified sources. GC Aesthetics is headquartered in Dublin.
CONTACT: Westwicke Partners Mark Klausner, 443-213-0500 email@example.comNEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...